Evolent Health (EVH) Stock Overview
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
EVH Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Evolent Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.67 |
| 52 Week High | US$25.22 |
| 52 Week Low | US$6.53 |
| Beta | 0.66 |
| 1 Month Change | -18.96% |
| 3 Month Change | -31.73% |
| 1 Year Change | -71.57% |
| 3 Year Change | -72.63% |
| 5 Year Change | -43.09% |
| Change since IPO | -64.63% |
Recent News & Updates
Recent updates
Insufficient Growth At Evolent Health, Inc. (NYSE:EVH) Hampers Share Price
Oct 29
Evolent Health, Inc. (NYSE:EVH) Stock Catapults 35% Though Its Price And Business Still Lag The Industry
Jul 14Why Investors Shouldn't Be Surprised By Evolent Health, Inc.'s (NYSE:EVH) 25% Share Price Plunge
May 30
New England Contract And Automation Will Drive Efficiency
Strong organic growth through expanded client agreements and sales pipeline is expected to boost revenue significantly.Benign Growth For Evolent Health, Inc. (NYSE:EVH) Underpins Its Share Price
Apr 14Evolent Health: Health Insurance Headwinds Aren't Helping Business - Rating Downgrade
Feb 27Analysts Have Lowered Expectations For Evolent Health, Inc. (NYSE:EVH) After Its Latest Results
Feb 22We Think Evolent Health (NYSE:EVH) Can Stay On Top Of Its Debt
Jan 04Evolent Health: A Shot At Revival After Market Bruising
Nov 12Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper
Nov 09We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)
Nov 07Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet
Sep 19Evolent Health: Let The Bidding Begin
Aug 23Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk
Jul 29Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Jul 01Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)
May 22These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well
May 05Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares
Apr 08Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital
Mar 12Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)
Dec 21Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
Nov 30A First Evaluation On Evolent Health
Oct 04Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital
Sep 01An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued
Aug 04Evolent Health: Business Economics Still Appealing, Reiterate Buy
Jul 19Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely
Jun 14Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30Shareholder Returns
| EVH | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -14.6% | -2.4% | 0.5% |
| 1Y | -71.6% | 22.9% | 20.1% |
Return vs Industry: EVH underperformed the US Healthcare Services industry which returned 22.9% over the past year.
Return vs Market: EVH underperformed the US Market which returned 20.1% over the past year.
Price Volatility
| EVH volatility | |
|---|---|
| EVH Average Weekly Movement | 8.7% |
| Healthcare Services Industry Average Movement | 9.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EVH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: EVH's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 4,500 | Seth Blackley | www.evolent.com |
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
Evolent Health, Inc. Fundamentals Summary
| EVH fundamental statistics | |
|---|---|
| Market cap | US$773.53m |
| Earnings (TTM) | -US$185.19m |
| Revenue (TTM) | US$2.20b |
Is EVH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EVH income statement (TTM) | |
|---|---|
| Revenue | US$2.20b |
| Cost of Revenue | US$1.84b |
| Gross Profit | US$359.26m |
| Other Expenses | US$544.45m |
| Earnings | -US$185.19m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 06, 2025
| Earnings per share (EPS) | -1.60 |
| Gross Margin | 16.36% |
| Net Profit Margin | -8.43% |
| Debt/Equity Ratio | 73.0% |
How did EVH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/02 17:18 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Evolent Health, Inc. is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| David Larsen | BTIG |
| Richard Close | Canaccord Genuity |